T1	Participants 217 295	a three-group, three-phase randomized clinical trial of a sample of 125 women.
T2	Participants 414 429	Control Group 1
T3	Participants 505 520	Control Group 2
T4	Participants 598 613	Control Group 1
T5	Participants 817 832	Control Group 2
T6	Participants 1001 1025	in-person support groups
